통합자연과학논문집 (Journal of Integrative Natural Science)

조선대학교 기초과학연구원 (The Basic Science Institute Chosun University)
권호 표지
DOI QR코드

DOI QR Code

Protein-Protein Interaction Analysis of Corticotropin - Releasing Hormone Receptor 1 with Corticotropin-Releasing Hormone and Sauvagine

  • 투고 : 2018.04.17
  • 심사 : 2018.06.25
  • 발행 : 2018.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Corticotropin - releasing hormone receptor 1 (CRHR1) forms an integral part of the pathophysiology of disorders like post-traumatic stress disorder, stress, anxiety, addiction, and depression. Hence it is essential to look for new, potent and structure-specific inhibitors of CRHR1. We have analysed the protein-protein interaction complexes of the CRHR1 receptor with its native ligand CRF and full agonist Sauvagine. The structure of Sauvagine was predicted using homology modelling. We have identified that the residues TYR253, ASP254, GLU256, GLY265, ARG1014 and LY1060 are important in the formation of protein-protein complex formation. Future studies on these residues could throw light on the crucial structural features required for the formation of CRHR1-inhibitor complex and in studies that try to solve the structural complexities of CRHR1.

키워드

참고문헌

  1. B. P. Grone and K. P. Maruska, "A second corticotropin-releasing hormone gene (CRH2) is conserved across vertebrate classes and expressed in the hindbrain of a basal neopterygian fish, the spotted gar", J. Comp. Neurol., Vol. 523, pp. 2015.
  2. R. L. Hauger, D. E. Grigoriadis, M. F. Dallman, P. M. Plotsky, W. W. Vale, and F. M. Dautzenberg, "Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands", Pharmacol. Rev., Vol. 55, pp. 21-26, 2003. https://doi.org/10.1124/pr.55.1.3
  3. N. Sato, K. Takagi, T. Suzuki, Y. Miki, S. Tanaka, S. Nagase, H. Warita, S. Fukudo, F. Sato, H. Sasano, and K. Ito, "Immunolocalization of corti-cotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial car-cinoma: CRHR1 as a potent prognostic factor", Int. J. Gynecol. Cancer, Vol. 24, pp. 1549-1557, 2014. https://doi.org/10.1097/IGC.0000000000000269
  4. F. Stamatelou, E. Deligeoroglou, N. Vrachnis, S. Iliodromiti, Z. Iliodromiti, S. Sifakis, G. Far-makides, and G. Creatsas, "Corticotropin-releasing hormone and progesterone plasma levels association with the onset and progression of labor", Clin. Exp. Obstet. Gynecol., 2013
  5. F. C. Raadsheer, J. J. van Heerikhuize, P. J. Lucas- sen, and W. J. Hoogendijk, "Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression", Am. J. Psychiatry, Vol. 152, pp. 1372-1376, 1995. https://doi.org/10.1176/ajp.152.9.1372
  6. H.-B. Fan, T. Zhang, K. Sun, S.-P. Song, S.-B. Cao, H.-L. Zhang, and W. Shen, "Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord", Tumor Bilogy, Vol. 36, pp. 9559-9565, 2015. https://doi.org/10.1007/s13277-015-3670-1
  7. V. Coric, H. H. Feldman, D. A. Oren, A. Shekhar, J. Pultz, R. C. Dockens, X. Wu, K. A. Gentile, S.?P. Huang, E. Emison, T. Delmonte, B. B. D'Souza, D. L. Zimbroff, J. A. Grebb, A. W. Goddard, and E. G. Stock, "Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder", Depress. Anxiety, Vol. 27, pp. 417-425, 2010 https://doi.org/10.1002/da.20695
  8. E. M. Jutkiewicz, S. K. Wood, and J. H. Woods, "The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adre- nocorticotropin in rats", Psychopharmacology (Berl.), Vol. 180, pp. 215-223, 2005. https://doi.org/10.1007/s00213-005-2164-z
  9. B. Binneman, D. Feltner, S. Kolluri, Y. Shi, R. Qiu, and T. Stiger, "A 6-week randomized, placebo-con- trolled trial of CP-316,311 (a selective CRH1 antag- onist) in the treatment of major depression", Am. J. Psychiatry, Vol. 165, pp. 617-620, 2008. https://doi.org/10.1176/appi.ajp.2008.07071199
  10. R. Pastor, C. S. McKinnon, A. C. Scibelli, S. Burkhart-Kasch, C. Reed, A. E. Ryabinin, S. C. Coste, M. P. Stenzel-Poore, and T. J. Phillips, "Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanism", Proc. Natl. Acad. Sci. U.S.A., Vol. 105, pp. 9070-9075, 2008. https://doi.org/10.1073/pnas.0710181105
  11. S. K. Nagarajan and T. Madhavan, "3D-QSAR studies of 8-substituted-2-aryl-5-alkylaminoquino-lines as corticotropin-releasing factor-1 receptor antagonists", J. Chosun Natural Sci., Vol. 8, pp. 176-183, 2015. https://doi.org/10.13160/ricns.2015.8.3.176
  12. (a) S. K. Nagarajan, T. Madhavan, "Comparative molecular similarity indices analysis (CoMSIA) of 8-substituted-2-aryl-5-alkylaminoquinolines as corticotropin-releasing factor-1 receptor antagonists", J. Chosun Natural Sci., Vol. 9, pp. 241-248, 2016. https://doi.org/10.13160/ricns.2016.9.4.241
  13. Y. Shen, J. Maupetit, P. Derreumaux, and P. Tufféry, "Improved PEP-FOLD approach for peptide and miniprotein structure prediction", J. Chem. Theory Comput., Vol. 10, pp. 4745-4758. 2014. https://doi.org/10.1021/ct500592m
  14. S. C. Lovell, I. W. Davis, W. B. Arendall III, P. I. W. de Bakker, J. M. Word, M. G. Prisant, J. S. Richardson, and D. C. Richardson, "Structure validation by Ca geometry: f, y and Cb deviation", Proteins, Vol. 50, pp. 437-450, 2003. https://doi.org/10.1002/prot.10286
  15. C. Colovos and T. O. Yeates," Verification of protein structures: patterns of nonbonded atomic inter-actions", Protein Sci., Vol. 2, pp. 1511-1519. 1993. https://doi.org/10.1002/pro.5560020916
  16. M. Wiederstein and M. J. Sippl, "ProSA-web: inter- active web service for the recognition of errors in three-dimensional structures of proteins", Nucleic Acids Res., Vol. 35, pp. W407-W410. 2007. https://doi.org/10.1093/nar/gkm290
  17. S. R. Comeau, D. W. Gatchell, S. Vajda, and C. Camacho, "ClusPro: an automated docking and dis- crimination method for the prediction of protein complexes", Bioinformatics, Vol. 20, pp. 45-50. 2003.
  18. S. C. Comeau, D. W. Gatchell, S. Vajda, and C. Camacho, "ClusPro: a fully automated algorithm for protein-protein docking", Nucleic Acids Res, Vol. 32, pp. 96-99, 2004.
  19. D. Kozakov, D. Beglov, T. Bohnuud, S. Mottarella, B. Xia, D. R. Hall, and S. Vajda, "How good is automated protein docking?", Proteins, Vol. 81, pp. 2159-2166, 2013. https://doi.org/10.1002/prot.24403
  20. M. F. Lensink and S. J. Wodak, "Docking, scoring, and affinity prediction in CAPRI", Proteins, Vol. 81, pp. 2082-2095. 2013. https://doi.org/10.1002/prot.24428
  21. D. Kozakov, R. Brenke, S. R. Comeau, and S. Vajda, "PIPER: An FFT-based protein docking program with pairwise potentials", Proteins, Vol. 65, pp. 392-406, 2006. https://doi.org/10.1002/prot.21117
  22. S. K. Nagarajan, "Protein-Protein Interaction Analysis of KiSS1-Derived Peptide Receptor with Kisspeptin-10 and Kisspeptin-15", J. Chosun Natural Sci., Vol. 11, pp. 9-13, 2018.
  23. B. Sathya, "Hologram Based QSAR Analysis of Xanthine Oxidase Inhibitors", J. Chosun Natural Sci., Vol. 10, pp. 202-208, 2017.